|
1
|
Marchesi F, Locatelli M, Solinas G, Erreni
M, Allavena P and Mantovani A: Role of CX3CR1/CX3CL1 axis in
primary and secondary involvement of the nervous system by cancer.
J Neuroimmunol. 224:39–44. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nelson PJ and Muenchmeier N:
Membrane-anchored chemokine fusion proteins: A novel class of
adjuvants for immunotherapy. OncoImmunology. 2:e266192013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yao X, Qi L, Chen X, Du J, Zhang Z and Liu
S: Expression of CX3CR1 associates with cellular migration,
metastasis, and prognosis in human clear cell renal cell carcinoma.
Urol Oncol. 32:162–170. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wada A, Ito A, Iitsuka H, Tsuneyama K,
Miyazono T, Murakami J, Shibahara N, Sakurai H, Saiki I, Nakayama
T, et al: Role of chemokine CX3CL1 in progression of multiple
myeloma via CX3CR1 in bone microenvironments. Oncol Rep.
33:2935–2939. 2015.PubMed/NCBI
|
|
5
|
Agalliu I, Xue X, Cushman M, Cornell E,
Hsing AW, Kaplan RC, Anastos K, Rajpathak S and Ho GY:
Detectability and reproducibility of plasma levels of chemokines
and soluble receptors. Results Immunol. 3:79–84. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rogers JT, Morganti JM, Bachstetter AD,
Hudson CE, Peters MM, Grimmig BA, Weeber EJ, Bickford PC and Gemma
C: CX3CR1 deficiency leads to impairment of hippocampal cognitive
function and synaptic plasticity. J Neurosci. 31:16241–16250. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dunn J, Lynch B, Rinaldis M, Pakenham K,
McPherson L, Owen N, Leggett B, Newman B and Aitken J: Dimensions
of quality of life and psychosocial variables most salient to
colorectal cancer patients. Psychooncology. 15:20–30. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Russell L, Gough K, Drosdowsky A,
Schofield P, Aranda S, Butow PN, Westwood JA, Krishnasamy M, Young
JM, Phipps-Nelson J, et al: Psychological distress, quality of
life, symptoms and unmet needs of colorectal cancer survivors near
the end of treatment. J Cancer Surviv. 9:462–470. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Grivennikov SI and Karin M: Inflammatory
cytokines in cancer: Tumour necrosis factor and interleukin 6 take
the stage. Ann Rheum Dis. 70 Suppl 1:i104–i108. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zigmond AS and Snaith RP: The hospital
anxiety and depression scale. Acta Psychiatr Scand. 67:361–370.
1983. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
American Joint Committee on Cancer (AJCC),
. AJCC Cancer Staging Manual. Edge SB, Byrd DR, Compton CC, Fritz
AG, Greene FL and Trotti A: 7th. Springer; New York, NY: pp.
1432010
|
|
12
|
Botega NJ, Bio MR, Zomignani MA, Garcia C
Jr and Pereira WA: Mood disorders among inpatients in ambulatory
and validation of the anxiety and depression scale HAD. Rev Saude
Publica. 29:355–363. 1995.(In Portuguese). PubMed/NCBI
|
|
13
|
Razavi D, Delvaux N, Farvacques C and
Robaye E: Screening for adjustment disorders and major depressive
disorders in cancer in-patients. Br J Psychiatry. 156:79–83. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Isozaki T, Kasama T, Takahashi R, Odai T,
Wakabayashi K, Kanemitsu H, Nohtomi K, Takeuchi HT, Matsukura S and
Tezuka M: Synergistic induction of CX3CL1 by TNF alpha and IFN
gamma in osteoblasts from rheumatoid arthritis: Involvement of
NF-kappa B and STAT-1 signaling pathways. J Inflamm Res. 1:19–28.
2008.PubMed/NCBI
|
|
15
|
Wang S, Liu Z, Wang L and Zhang X:
NF-kappaB signaling pathway, inflammation and colorectal cancer.
Cell Mol Immunol. 6:327–334. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Miranda D Oliveira, de Lima TA Soares,
Azevedo L Ribeiro, Feres O, da Rocha JJ Ribeiro and
Pereira-da-Silva G: Proinflammatory cytokines correlate with
depression and anxiety in colorectal cancer patients. BioMed Res
Int. 2014:7396502014.PubMed/NCBI
|
|
17
|
Zujovic V, Schussler N, Jourdain D,
Duverger D and Taupin V: In vivo neutralization of endogenous brain
fractalkine increases hippocampal TNFalpha and 8-isoprostane
production induced by intracerebroventricular injection of LPS. J
Neuroimmunol. 115:135–143. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Briones TL, Woods J and Wadowska M:
Retraction Note: Chronic neuroinflammation and cognitive impairment
following transient global cerebral ischemia: role of
fractalkine/CX3CR1 signaling. J Neuroinflammation. 12:2202015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hellwig S, Brioschi S, Dieni S, Frings L,
Masuch A, Blank T and Biber K: Altered microglia morphology and
higher resilience to stress-induced depression-like behavior in
CX3CR1-deficient mice. Brain Behav Immun. 55:126–137. 2016.
View Article : Google Scholar : PubMed/NCBI
|
